SCHEMBL8526330

SCHEMBL8526330

Fc1cccc(-c2cnc3ccc(C=Cc4ccccc4)cc3c2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NFE2L2 Q16236 9/20 0.53
PDGFRB P09619 3/20 0.51
PDGFRA P16234 3/20 0.51
BIRC5 O15392 1/20 0.43
RELA Q04206 3/20 0.41
TUBB4A P04350 2/20 0.41
TUBB P07437 2/20 0.41
TUBA3C P0DPH7 2/20 0.41
TUBA1B P68363 2/20 0.41
TUBA4A P68366 2/20 0.41
TUBB4B P68371 2/20 0.41
TUBB3 Q13509 2/20 0.41
TUBB2A Q13885 2/20 0.41
TUBB8 Q3ZCM7 2/20 0.41
TUBA3E Q6PEY2 2/20 0.41
TUBA1A Q71U36 2/20 0.41
TUBA1C Q9BQE3 2/20 0.41
TUBB6 Q9BUF5 2/20 0.41
TUBB2B Q9BVA1 2/20 0.41
TUBB1 Q9H4B7 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8526328 1.00 NFE2L2 (0.53) NFE2L2PDGFRBPDGFRABIRC5RELA
SCHEMBL8501972 0.80 NFE2L2 (0.47) NFE2L2PDGFRBPDGFRATUBB4ATUBB
SCHEMBL8887518 0.80 NFE2L2 (0.47) NFE2L2PDGFRBPDGFRATUBB4ATUBB
SCHEMBL8879268 0.78 KMT2A (0.57) PDGFRBPDGFRARELATUBB4ATUBB
SCHEMBL8879272 0.78 KMT2A (0.57) PDGFRBPDGFRARELATUBB4ATUBB
SCHEMBL9092449 0.78 PDGFRB (0.48) PDGFRBPDGFRABIRC5
SCHEMBL8896335 0.78 PDGFRB (0.48) PDGFRBPDGFRABIRC5
SCHEMBL29375750 0.76 PDGFRB (0.54) PDGFRBPDGFRABIRC5RELAKDM4E
SCHEMBL8499693 0.74 PDGFRB (0.52) PDGFRBPDGFRAKDM4ENPC1ALDH1A1
SCHEMBL14077283 0.74 PDGFRB (0.58) PDGFRBPDGFRABIRC5RELAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5646153-A INHIBITING ABNORMAL CELL PROLIFERATION RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1997-07-08 US claimed
US-RE36256-E ADMINISTERING ARYL-SUBSTITUTED QUINOXALINE DERIVATIVES AS ANTIPROLIFERATIVE, ANTICARCINOGENIC AND ANTITUMOR AGENTS RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) 1999-07-20 US disclosed
US-5646153-A INHIBITING ABNORMAL CELL PROLIFERATION RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1997-07-08 US disclosed
US-5480883-A Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1996-01-02 US disclosed